Stay updated on SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, indicating a newer version of the study record. This reflects a minor administrative update that does not change the study content or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-04-30T18:54:05.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision note updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:28:04.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Updated the follow-up time frame for several outcomes. The period from 91 days through completion of follow-up (estimated 24 months) was replaced with 91 days through 12 months post-SBRT or 90 days after the last defactinib dose, whichever comes first (estimated 12 months 5 days).
    Difference
    0.3%
    Check dated 2026-03-26T02:32:51.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T20:40:01.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T17:44:37.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Administrative updates to the study record show revised start and completion dates and a new last-update timestamp. The updated timeline reflects changes to the trial's schedule.
    Difference
    0.4%
    Check dated 2026-02-18T07:01:06.000Z thumbnail image

Stay in the know with updates to SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.